Institute of Molecular Biomedicine CUFM

IMBM is the research institute of the Faculty of Medicine at the Comenius University. It is located in the Old town of the capitol of Slovakia – Bratislava on the Sasinkova street 4. The mission of IMBM is simple: (doing and enjoying doing) interesting and meaningful science. The educational background of the staff includes molecular biology, biotechnology, physiology and medicine. Interdisciplinarity has a value on its own. We collaborate with clinicians and complementary scientists all around the globe (Aachen, Gothenburg, Boston, Hradec Králové…). PhD students are trained at our institute in experimental and laboratory medicine. Undergraduate students are working on their bachelor/master/doctoral theses at IMBM. People at IMBM teach at the Faculty of Medicine and the Faculty of Natural Sciences.

News

Motivational rewards for PhD students

Faculty of Medicine, Comenius University, grants PhD students with motivational rewards:

  • publication in a CC journal: 500€ + (impact factor x 100€)
  • publication in a non-CC journal: 250€ + (impact factor 50€)
  • publication activity from previous year will be awarded again according to the first authorships and coauthorships as well as the Hirsh index
  • successful PhD defence in term: 1000€

You can find the complete internal regulation regarding rewards in Slovak language here.

June 29, 2017

Science

Projects

  • VEGA: Early molecular markers of myocardial infarction
  • APVV: Metabolic syndrome in adolescent children
  • VEGA: Effect of testosterone and estradiol in kidney fibrosis development using recurrent urinary tract infection

Published papers

  • Identification of the deletions in the UGT1A1 gene of the patients with Crigler-Najjar syndrome type I from Slovakia.
  • Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
  • Detection of His1069GIn mutation in Wilson disease by bidirectional PCR amplification of specific alleles (BI-PASA) test.